Shows
The Crux of MedtechDual-Modality Imaging That Rewrites PCI Outcomes with Thomas Looby, CEO of Conavi MedicalIn this episode of the Crux of Medtech Henry is joined by Thomas Looby, CEO of Conavi Medical.Thomas breaks down why combining IVUS + OCT in a single catheter could change coronary interventions and how the team is pacing toward a Q3 2025 510(k) with a measured “crawl, walk, run” launch plan.Expect candid insight on evidence, pricing, commercialisation, and strategic exit logicKey TopicsThe unmet need in PCI imaging and why single-modality tools leave blind spots.Engineering IVUS + OCT into one catheter and...
2025-09-0342 min
The Crux of MedtechHow to Survive FDA Battles and Boardroom Drama - with Sabine BoisThis episode of the Crux of Medtech features Sabine Bois, the former CEO of Occlutech.Sabine is a medtech leader whose career spans founding startups, steering a company through bankruptcy, driving IPO prep, and ultimately leading as CEO.Her story is raw, unfiltered, and filled with lessons about resilience, leadership, and navigating the brutal realities of medtech.Key Topics:Sabine’s leap from small-town Germany to founding her first medtech startupNavigating bankruptcy and rebuilding into a successful acquisitionThe commercial lessons that reshaped her career trajectory...
2025-08-2754 min
The Crux of MedtechThe AI Solution That Targets Repeat Cancer Surgeries - with Adrian MendesIn this episode, Henry Norton speaks with Adrian Mendes, CEO of Perimeter, a company using AI and optical imaging to tackle one of cancer surgery’s biggest problems: re operationsAdrian shares his journey from Silicon Valley tech to medtech, and unpacks how Perimeter is using real-time imaging and machine learning to give surgeons confidence they’ve removed all the cancer the first time.They discuss the challenges of moving fast in healthcare, the value of proprietary data in AI, and how Perimeter is building for scale with a clea...
2025-08-2055 min
The Crux of MedtechWhy Digital Health Keeps Failing Patients - with David PettigrewWhy are so few patients accessing the care they need when the tech is already here? In this episode, Henry Norton sits down with David Pettigrew CEO at my mhealth to unpack the real reasons digital health tools succeed or fail.From overlooked rehabilitation gaps to the power of patient-first design, this conversation spotlights how we can actually get medtech into the hands of the people who need it most.David shares his career pivot from corporate dream job to healthtech entrepreneur, and what it’s really like building pr...
2025-08-1354 min
The Crux of MedtechWhat's the Hype with Neuro? A Lesson in the Brain - With Hannah ClaridgeIn this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions. Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation. She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body. Hannah also suggested that neurotherapy will be key...
2025-07-021h 00The Crux of MedtechWhy Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUSRaising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018.In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall.He also explores the changing landscape of Medtech innovation and why strategic exits take years of...
2025-06-2552 min
The Crux of MedtechClinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin DentalJoin host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental.Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics.In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, an...
2025-06-1859 min
The Crux of MedtechArtificial Intelligence Feels Like Magic - With Peter VerrilloMeet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI. Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre. Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement. He also emphasises the benefits of working with device-manufacturing companies, as they will take his...
2025-05-2846 min
The Crux of Medtech“AI is not Taking the Lead, AI is the Enabler” - With David CaumartinJoin your host, Henry Norton, and David Caumartin, the CEO of RebrAIn, as they discuss the impact that machine learning and artificial intelligence are having on the clinical outcomes of neurosurgery procedures. During the episode, David shares his medtech story, from how he entered the field to what drew him to RebrAIn several years ago. He also talks about his experience of working with neurosurgeons and how that differs from the other fields he specialised in, such as mammography. David goes on to discuss the benefits of AI in the surgical space, suggesting tha...
2025-05-2152 min
Cyber BitesCyber Bites - 16th May 2025Pearson Educational Giant Suffers Major Cyberattack Through Exposed GitLab Tokenhttps://plc.pearson.com/en-GB/news-and-insights/news/cyber-security-incidenthttps://www.bleepingcomputer.com/news/security/education-giant-pearson-hit-by-cyberattack-exposing-customer-data/Malicious npm Packages Target Cursor Editor Users, Affecting Over 3,200 Developershttps://socket.dev/blog/malicious-npm-packages-hijack-cursor-editor-on-macosCyber Scammers Deploy Fake AI Creation Tools to Spread Noodlophile Malware via Facebookhttps://www.morphisec.com/blog/new-noodlophile-stealer-fake-ai-video-generation-platforms/Google Deploys On-Device AI to Combat Scams Across Chrome, Search, and Androidhttps://blog.google/technology/safety-security/how-were-using-ai-to-combat-the-latest-scams/New Investment Scams Employ...
2025-05-1512 min
The Crux of MedtechMaking Difficult Intubation a Thing of the Past - With Dimitri SokolovIn this episode, your host, Henry Norton, is joined by Dimitri Sokolov, the CEO at Spiro Robotics, to talk about the limitations of laryngoscopy tools, and what Spiro is doing to remove them. Dimitri explained the difficulties with current intubation methods, as well as the dangers of unsuccessful procedures. He went on to discuss the challenges of getting FDA approval for a new piece of medical robotics. Dimitri also shared some of the adjustments he’s had to make as he moved into the role of CEO, particularly in a small company. This inclu...
2025-05-1440 min
The Crux of MedtechSurgeons are Operating Blind but They Don't Need To - With Oliver Delporte, CEO of SamanTree MedicalMeet this week’s guest, Olivier Delporte, the CEO of SamanTree Medical. He joined me, your host, Henry Norton, to discuss his company’s game-changing imaging technology, which is set to improve surgical outcomes for cancer patients in the breast and prostate areas. Oliver also has an extensive background in venture capital, which he says compliments his role as CEO, as it allows him to build the company to a point that it is attractive to investors. He also discussed the innovations behind the Histolog Scanner, including the current imaging systems and their failings, which prompt...
2025-05-0754 min
The Crux of MedtechHow Surgical Robotics Can Make ‘Average Clinicians’ as Good as the Best Surgeons - With Paul Galluzzo & Steve BellThis episode of the Crux of Medtech podcast has not one, but two guests, who joined me at TTP’s offices for an exciting conversation about the future of surgical robotics - and that’s the best name for the technology we’re exploring. I’m delighted to introduce Paul Galluzzo, Head of Surgical Intervention and Imaging at TTP, and Steve Bell, an independent Medtech startup advisor. They discussed the ways that our technology needs to evolve in order to improve surgical outcomes and quality of life for patients, as well as the enhanced laparoscopic applicatio...
2025-04-301h 06
The Crux of MedtechTrying to operate chopsticks in a matchbox - With Manios Dimitrakakis, CEO of Panda Surgical - With Manios DimitrakakisWelcome to the first ever episode of the Crux of MedTech podcast!I’m your host, Henry Norton, and in this series I’ll be introducing you to some of the leading innovators and investors in the surgical robotics space, to share their stories and insights. This week, I’m joined by Manios Dimitrakakis, the CEO of Panda Surgical. He talks about his journey from academia to industry, following his path from post-graduate researcher to his current role as CEO of an exciting young MedTec...
2025-04-2359 min
Invent: Life SciencesFrom Promise to Practice – AI's Impact on Cell and Gene Therapy DevelopmentIn this episode, Stuart explores the adoption of generative AI in the pharmaceutical industry, with a special focus on cell and gene therapy. While the application of AI for drug discovery has been well documented and a source of considerable investment for the pharmaceutical sector, we are only just starting to see its impact for therapy developers. A 2024 report from McKinsey Global Institute estimates that generative AI could generate up to $100 billion in economic value for pharma and medical product companies, and therapy developers are eager to see these benefits sooner rather than later, no more so than in...
2025-01-2734 min
Invent: Life SciencesFrom Plastics to Partnerships - The Path to Sustainability in BiopharmaIn this episode, host Stuart explores what the sustainability goals of Big Pharma mean for those organisations, and the companies that support them. With insights from Ryan Walker, Sustainability Program Leader at Cytiva, and Wenshu Xu, Drug Discovery Tools Team Lead at TTP, we review the progress made by the industry so far and some examples where innovative thinking has had an impact on operations. Topics include the challenge of tackling Scope 3 emissions, reducing the impact of single-use plastics, and how collaboration across the ecosystem is key to meeting ambitious sustainability targets.Guests:Ryan Walker, Sustainability...
2025-01-1340 min
Invent: Life SciencesHow Climate Change and AI are Driving Innovation in BiopharmaIn this two-part series, host Stuart Lowe examines two factors testing the resilience of the biopharma industry. As society simultaneously navigates a green transition alongside an AI revolution, so the biopharma industry faces mounting pressure to address its carbon emissions, deploy cutting-edge digital technology, while streamlining operations. Along with his guests, discover the innovative approaches that are being taken to transform drug development and manufacturing.
2025-01-0602 min
The Crux of MedtechTop Mistakes Surgical Robotics Companies Make in Technology Development - Paul Galluzzo - TTP PLCDiscover the importance of strong value propositions when developing a new surgical robot with your host, Henry Norton, and Paul Galluzzo, the ??? at The Technology Partnership (TTP).
Paul also shared his predictions for upcoming technologies in the surgical robotics industry, including augmented reality and artificial intelligence, as they continue to enhance surgeons’ skills.
He also shared his insights on what makes a business in the sector successful, citing the importance of resources and market share when taking a new robot to market.
Paul also sh...
2024-12-051h 02
The Crux of MedtechFlexibility, Accessibility, Simplicity: Dexter’s Approach to Robotics - Greg Roche – DistalmotionTake a look at the inner workings of Distalmotion with CEO Greg Roche and your host, Henry Norton, in this fascinating episode!
Greg shared the importance of the company’s value proposition in taking Dexter, their surgical robot, to a global market.
They also touched on the evolution of surgical robotics, both in technical terms and its increasing adoption in new generations of surgeons.
Tune in to discover more about innovation in smaller surgical robotics players.
The Surgibots Podcast is...
2024-11-2846 min
The Crux of MedtechDon’t Believe The Hype – We Need More Clinical Evidence - Mark Slack - CMR SurgicalDelve into the topic of evidence and value-based medicine with your host, Henry Norton, and Mark Slack, the Chief Medical Officer and Co-Founder of CMR Surgical.
Mark joined us to share his experience of working with surgical robotics and the impact they have on patient outcomes.
He also shared his perspective on using untested technologies and the serious impact this can have on the health and wellbeing of hundreds, or even thousands, of patients.
Throughout the conversation he highlighted the importance of patient-first care...
2024-11-2154 min
The Crux of MedtechPimp My Robot – How Ultrasonics Will Get Better Outcomes - Nico Fenu - Nami SurgicalExplore the applications of ultrasound in surgical robotics with your host, Henry Norton, and Nico Fenu, the Co-Founder and CEO of Nami Surgical.
Nico explained the variety of ultrasound applications within the surgical robotics industry, from ultrasonic imaging to biopsies and precision surgery.
He also explained the technical side of developing an ultrasound application, as well as Nami Surgical’s process of spinning out from a university research centre.
Tune in to hear more about this exciting branch of surgical development.
...
2024-11-1451 min
The Crux of MedtechThe World’s First Arthroscopic Robot - Chris Jeffrery - Convergence MedicalExplore the realms of sports medicine and arthroscopy with your host, Henry Norton, and Chris Jeffery, the CEO of Convergence Medical.
Chris explained his journey into arthroscopy, touching on his history as a three-time founder and his passion for improving healthcare.
They also discussed the importance of adapting technology to changing market demands, from financial constraints to surgeon’s limited capabilities.
Tune in to hear more about improving accuracy and dexterity with surgical robotics.
The Surgibots Podcast is brought to...
2024-11-0754 min
The Crux of MedtechHow to do Remote Surgery, 2001 to 2024 - Cynthia Perazzo & Yulun Wang - SovatoDiscover telesurgery’s fascinating origin and future in this double-feature episode with Cynthia Perazzo and Yulun Wang, the Co-Founders of Sovato.
Your host, Henry Norton, guided the conversation through topics such as patient-driven adoption to the potential for healthcare revolution.
Cynthia and Yulun also discussed surgeon shortages and the accessibility challenges facing more rural and remote populations in receiving a high standard of care.
Listen in to learn more about technology’s role in transforming healthcare in the coming years.
Th...
2024-10-3158 min
The Crux of MedtechThe Biggest Competition for Surgical Robotics Companies - Bjoern von Siemens – CaresyntaxExplore the complexity of clinical data with Bjoern von Siemens, the Founder of Caresyntax and this week’s guest speaker.
In this episode, hosted by Henry Norton, Bjoern discussed the future of MedTech, including the role that data and AI will play in developing the technology that is currently set to transform surgery for future generations.
They also touched on the importance of reducing the cost of care and making safe surgery accessible to everyone.
Tune in to learn more about the role of au...
2024-10-2453 min
The Crux of MedtechWhy Developing Soft Tissue Robots isn't for the Faint of Heart - Rajit Kamal – MedtronicDiscover the potential of technology in the healthcare industry with Henry Norton and Rajit Kamal, the VP and General Manager of Medtronic.
Rajit shared his impressive background as a MedTech leader, touching on the importance of cultural alignment in choosing his next role.
The conversation also touched on the commercial benefits of competition, acquisitions and innovation.
Tune in to find out more about the impact of robotics and other emerging technologies in the medical field.
The Surgibots Podcast is...
2024-10-1751 min
The Crux of MedtechWant to Build a Competitive Robot? Build for the ASC - Sabeen Shaikh - Life Science ConsultantsJoin your host, Henry Norton, and this week’s guest Sabeen Shaikh, a Partner in Global MedTech at Life Science Consultants, as they discuss the future of orthopaedic robots.
During the episode, Sabeen shared her journey into surgical robotics, as well as her insights into the business decisions driving them forwards.
The conversation also touched on topics such as workflow efficiency and patient outcomes.
Tune in to hear a fresh perspective on the surgical robotics of the future.
The Surgibo...
2024-10-1046 min
The Crux of MedtechLaunching Shoulder Robots to the World - Nnamdi Njoku - Zimmer BiometWelcome to Season 3 of The Surgibots Podcast!
To kick off the new series, your host, Henry Norton, spoke with Nnamdi Njoku, the President of Sports Medicine, Surgical, Upper Extremities & Restorative Therapies at Zimmer Biomet, about the complexity of developing new soft tissue applications for surgical robotics.
Nnamdi also shared his impressive professional history, including a long tenure at Medtronic, as well as the factors that drew him to Zimmer Biomet.
They also touched on the importance of understanding your clients, whether that’s the end p...
2024-10-031h 03
Invent: Life SciencesHow Innovation Can Broaden Access and Propel the CGT Industry ForwardIn Part One of this two-part series, we reflected on the progress made in the Cell and Gene Therapy (CGT) industry and the importance of patient-centric development. In this episode, we dive into how we can continue to move forward, broaden access, and encourage the development of new treatments. We’ll discuss the critical need to scale manufacturing, even in the early stages of development, to ensure that these therapies reach the patients who need them.Guests:Emma Chan, Director of Technical Development at Orchard TherapeuticsMatt Hewitt, Chief Technical Officer at the Manufacturing Bu...
2024-09-2347 min
Invent: Life SciencesWhy Do We Need to Continue Innovating in the CGT Industry?The Cell and Gene Therapy (CGT) industry has made remarkable strides, with significant advancements and the approval of groundbreaking technologies in recent years. However, have we become too dependent on older methods, and are we doing enough to ensure these new therapies are reaching as many patients as possible? In this episode, we tackle these questions while exploring one fundamental issue: Why? Why is it essential to continue innovating to broaden patient access, develop new therapies, and push the industry forward?Guests:Tay Salimullah, Chief Access Commercial Officer at NovartisJason Jones, Global Business Development Lead at...
2024-09-1646 minInvent: Life SciencesWelcome Back to Invent: Life Sciences - Season 3 TrailerWelcome back to Invent: Life Sciences, a podcast brought to you by technology and product development company TTP. With approvals for advanced therapies on the rise, and aspirations to target larger patient populations, it’s time to take stock and reflect and on the progress made to date. In this series, we’ll be looking at the people, processes and partnerships we’ll need to continue moving forwards and delivering the best outcomes for the greatest number of patients.Over the forthcoming two episodes, I’ll be joined by 4 expert g...
2024-09-0901 min
Invent: Life SciencesThe Highlights: A look back at the best moments of Invent: Life Sciences Series 2
Throughout this series of Invent, we have brought you cutting-edge developments in the Life Sciences industry. We have spoken to a wide range of guests who have provided fascinating insights into the manufacture of cell and gene therapies, and what developments in drug testing mean for the future of genetic research. A big thank you to all our guests that featured in this series, make sure you show your appreciation to our esteemed guests by re-listening to your favorite episode and subscribing to Invent: Life Sciences from wherever you get your podcasts. And fin...
2023-11-1514 min
Invent: Life SciencesProcess Analytics: how can analytics accelerate the development and manufacture of cell and gene therapies?
Throughout this series, we’ve explored different diseases we target, the sorts of cells which are under development as therapies, and how the therapies themselves are manufactured. With all this innovation, we shouldn’t be surprised by the increased focus on the means by which processes and products themselves are characterised. So, do current process analytical tools provide the insights therapy developers need? And how can new technologies be implemented in the fast-moving life sciences field?To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product deve...
2023-11-0839 min
Invent: Life SciencesiPSCs: how could stem cells revolutionise the manufacture of advanced therapies?
Across the life sciences industry, there is much excitement over the potential impact of stem cells in medicine. And it is clear why; these cells, which can be differentiated into any other cell type, could rewrite the playbook in terms of sourcing cellular material for advanced therapies manufacture. So how might therapy developers benefit from the unique abilities of stem cells? And will they live up to their expectations?To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.This Week's...
2023-11-0138 min
Invent: Life SciencesSex and gender in medical research: how can a focus on the individual improve health outcomes for marginalised groups?
Throughout almost all of medical history, it was assumed that the average white male response to drug trials could be extrapolated to all potential recipients. But when we look at the poorer health outcomes for women and minorities, could the underlying assumptions in medical research be a contributing factor? If so, what is being done to solve them?To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.This Week's GuestsDiana TorgersenDiana Torgersen is the Executive...
2023-10-2535 min
Invent: Life SciencesOrganoids: how are in-vitro models revolutionising drug development and testing?
Pharmaceutical companies undertake rigorous clinical trials in order to find out which drugs are safe. But in order to better protect the people volunteering for these tests, regulators decreed that data from studies on animals would be the primary evidence needed before approving a clinical trial in humans. Testing drugs on animals has many ethical and practical issues, and so scientists are looking towards different types of in-vitro models as a solution. But what are these models? How can they move us towards safer, better trials?To find out, join us on Invent: Life...
2023-10-1834 min
Invent: Life SciencesThe Blood Brain Barrier: can innovations in delivery help us unlock the brain?
Modern medicine has helped us develop many effective treatments for diseases found throughout the body, but we’ve yet to have the same success with the brain. The so-called 'blood brain barrier' controls the passage of molecules out of the blood and into the brain, and so it’s not as easy to use the bloodstream to carry therapeutic molecules as we might do for other diseases. Could the blood brain barrier be the key to treating neurological disorders? How can we target this structure to make therapies more effective?To find out, join us o...
2023-10-1138 min
Invent: Life SciencesSmall Molecules: can new classes of drug target reinvigorate drug discovery?
In the pharmaceutical industry, there is a desire to go beyond the traditional ‘compound x acts on protein y,’ and achieve a more nuanced effect on the underlying biology. So, could innovative approaches to small molecules open up a wider application space? And what benefits might this bring to cash-strapped healthcare systems?To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.This Week's GuestsAnne HorganAnne Horgan is a partner at Cambridge Innovation Captial, a vent...
2023-10-0440 min
Invent: Life SciencesCell and gene therapy: how can we transform artisan treatments into mass-market cures?
Cell and gene therapies are extremely effective but their complex production processes, arduous supply chain, and life-critical logistics have prevented mass market adoption. Could digitisation and AI provide a breakthrough in manufacturing? Would more companies be willing to work together on standardisation to provide more flexibility?To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.This Week's GuestsMatthew DurdyMatthew Durdy is a biologist, investor, entrepreneur, and the Chief Executive of the Cell and Therapy...
2023-09-2737 min
Invent: Life SciencesmRNA: What did Covid teach us about drug development and distribution?
The Covid vaccination campaign demonstrated the effectiveness of mRNA-based treatments, so what else is this technology capable of? How can we improve our manufacturing and distribution to ensure treatments are available to those who need them most? To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.What is mRNA and what is the importance of mRNA treatments?Messenger ribonucleic acid, or mRNA for short, is a crucial molecule in the process of making proteins in our bodies. Proteins are essential f...
2023-09-2038 min
Invent: Life SciencesmRNA: What did Covid teach us about drug development and distribution?The Covid vaccination campaign demonstrated the effectiveness of mRNA-based treatments, so what else is this technology capable of? How can we improve our manufacturing and distribution to ensure treatments are available to those who need them most? To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.What is mRNA and what is the importance of mRNA treatments?Messenger ribonucleic acid, or mRNA for short, is a crucial molecule in the process of making proteins in our bodies. Proteins are essential f...
2023-09-2038 min
Invent: Life SciencesIntroducing Invent: Life Science Series 2
Invent: Life Sciences is back for Season 2! Invent: Life Sciences is a podcast about the future of life science and technology, hosted by Head of Cell Gene Therapy and Biotechnology at TTP, Stuart Lowe.Each episode, we’ll be joined by the top scientists, designers, business leaders, and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of life science.In this new season, we now turn our focus onto advances driving forward the pharmaceutical sector, and how life scientists are dedicating their lives to...
2023-09-1302 min
Invent: HealthThe Power of Big Data
Over the course of this season, one thing has kept coming up across all the episodes - the power of big data in health tech. From its uses in the current AI revolution, to universal health records and even in new sustainable practices, the way in which huge data sets are allowing health practitioners to create new products and services is as fascinating as it is exciting. So in this season’s final episode, we take a look at the kind of utopian world that could exist when data is harnessed properly in the entire healthcare ecosystem, and...
2023-05-1736 min
Invent: HealthRapid Innovation: Reducing Time from Idea to Impact
Speed is not normally something you would associate with the highly regulated world of health tech. “Rapid” time frames tend to be in the space of 3-5 years. But the Covid panic changed this - the war footing it caused brought times down enormously. It’s something that TTP played a hand in as well with Covent, TTP’s rapid manufacture ventilator for COVID-19 patients. So what can we learn from this period to bring to normal times? How can health tech practitioners work with regulators and the NHS to ensure new innovations move from idea to impact as quickly...
2023-04-1935 min
Invent: HealthCardiac Health: Prevention or Intervention?
There’s a multitude of ways to treat Cardiac issues, and it’s about more than just health tech. While technologies that intervene after a cardiac event has taken place are coming on leaps and bounds - from ablation catheters to pacemakers - preventative measures are seen by many as the way forward. Whether it is improved sensing technologies, the rise of telehealth, or even promoting good lifestyle factors, stopping cardiac issues even happening in the first place is a first port of call for many clinicians. But which is more significant? What’s the way forward? And how do we...
2023-04-0533 min
Invent: HealthDesigning for Trust: How to Create Trust in Health Tech
Trust in healthcare is one of the highest for any industry, but it’s a different story for the technology sector. People will inherently trust their doctor, but social media, or medical advice from the internet? Much less so. But as healthcare and technology become ever more entwined, how do those designing healthcare’s digital products ensure those using them will trust them? What will the consequences of falling trust in technology mean for health tech? And what does it take to make you trust someone in general? In this episode of Invent: Health...
2023-03-2234 min
Invent: HealthImaging Technologies: Smaller, Cheaper, Better?
Medical imaging technologies have long been dominated by big, expensive machines that take up their own room within hospitals. The level of detail they can give is extensive and vital, and they are now even developing new fusion technologies that can combine nuclear, ultrasound, and MRI technologies together. But there is a new range of technologies coming into the market which are changing the way we think about imaging. These devices are more portable, and cheaper, allowing true point of care for patients, while also unlocking imaging in new realms of healthcare. In this episode of...
2023-03-0831 min
Invent: HealthSustainability: A New Paradigm
Sustainability is a word now ubiquitous in healthcare. But too often it is thought about with a short-sighted lens, promoting potentially superficial changes in micro areas over innovations that would reduce healthcare’s carbon footprint on a macro level. So how can we solve this? What could a new paradigm for discussing sustainability in healthcare look like?In this episode of Invent Health, we meet the people seeking to create one, by focusing on the wider impact of medical devices to keep people out of hospital, with the potential to reduce carbon footprints on a hu...
2023-02-2231 min
Invent: Life SciencesIntroducing Invent: Health Series 2
Calling all Invent: Life Sciences Subscribers! While you wait for more episodes, make sure to subscribe to our sister podcast, Invent: Health, which has just begun its second season. Listen to the trailer here now! Invent: Health sees host Matt Parker explore the fascinating future of Health technologies. From new closed-loop systems for diabetes to sensing innovations in cardiac health, Matt will be taking a look behind the scenes of these technologies and meeting the people working to transform our collective health.Listen and subscribe from anywhere you get your podcasts, just search...
2023-02-1302 min
Invent: HealthEpilepsy: Understanding the brain when neurological disorders occur
Neurological disorders have a really significant patient burden, with some estimates suggesting the impact as many as 1 billion people across the globe. But simultaneously, these are diseases which are both challenging to treat and still remain relatively poorly understood.Snapshots of the brain have been available through imaging technologies for a while, but coming up with devices that are able to monitor the brain in real time has proved a huge challenge.Today we ask, what will improvements to continuous monitoring devices enable for the diagnosis and treatment of neurological disorders?In the...
2023-02-0836 min
Invent: HealthDiabetes Monitoring: Human out of the loop
In this first episode of Invent:Health Season 2, Matt Parker speaks to Chris Dawson, Head of Biosensing at TTP, and Dr. Andrew Chapman, CEO, and Co-Founder of Carbometrics, to explore how patients can be taken out of this monitoring-delivery loop and what technologies are out there that can automate the process entirely. This Week's GuestsChris Dawson - Dr. Chris Dawson is a mechanical engineer who leads the biosensing team at TTP. The team works with clients to leverage advances in biosensing technology to develop products that support patients in managing and treating a wide range...
2023-01-2534 min
Invent: HealthInvent:Health from TTP - Season 2 Trailer
Today we launching the trailer for the Invent Health podcast. Each week we're going to be joined by the top scientists, engineers, and academics working to give you a behind-the-scenes look at the world of health tech.
2023-01-1802 min
Invent: HealthBehavioural Science: How to do what's good for us
Doing what’s good for you should seem like second nature, so why is it that we as humans so often don’t do things which we know will be effective when it comes to our own health and wellbeing? From difficulties in quitting smoking to the 25% of prescriptions in the UK that are left unfilled, medical non-adherence has profound effects on the health of a population, and it’s also one of the trickiest realms for health practitioners to deal with. How do you literally change someone’s behaviour if they already know they’re doing themselves harm?Find...
2022-12-1437 min
Invent: HealthMental Health: How to think about feeling
There is now a widespread awareness of the gravity of mental health issues in the general public, and equally in the world of healthcare. But in tandem with its rise we've seen the growth of the so-called "wellness industry", which too often promotes pseudo scientific solutions to the most complex of problems. So how is the health tech industry responding? What are the new frontiers for digital therapeutic care today, especially in the post-pandemic landscape?Find out on this week's episode of Invent: Health from TTPThis Week's GuestsAdonis Bou Chakra is...
2022-12-1444 min
Invent: HealthNeurotech: How to speak to the brain
Neurotech: what is it? Elon Musk’s brain implants that herald a dystopian sci fi future? Or life saving technology which will be able to cure a multitude of injuries: back pain, epilepsy, even paralysis. In this episode of Invent: Health, we take a look at the hype vs the reality in the thrilling field of neurotech, speaking to experts from TTP and beyond to break it down and find out about its history, its current applications and the incredible places it’s going in the future.Find out more on this week's episode of Invent: Health from...
2022-12-1432 min
Invent: HealthEyecare: How to restore sight
Of all the senses, sight is perhaps our most important. The eye is one of the most incredible organs in nature: it enables us to perceive the world around us, understanding our world through images. And yet we only see a small aspect of reality. But the eye is important beyond just sight. It can also provide a window into our overall health, showing indicators for other things like alzeihmers and blood pressure. In this episode of Invent Health we breakdown the world of modern eyecare to find the ways that tech is improving our collective vision. We’ll he...
2022-12-1442 min
Invent: HealthSustainable Healthcare: How to take action
Humans are designed to make decisions in the now, not ones in the abstract long term. That’s why ‘cathedral thinking’ comes so hard to us - so it's understandable that making healthcare more sustainable is hard when its primary function is first and foremost to save lives today, not the planet tomorrow. It's easy to say you want to be more sustainable but when you're dealing with people's lives, does sustainability go out of the window? So what can we actually do? This episode of Invent: Health sees us explore the difficulties and challenges as healthcare industries try to bec...
2022-12-1438 min
Invent: HealthSurgical Robotics: How to build a robot
Surgical robotics are all the rage right now. Attracting huge investment from the biggest names in healthcare devices, the use of robots in surgery has the potential to change the industry in some really profound and exciting ways. However, some have criticised their implementation as an unnecessary expense when humans can perform these tasks just as well. This episode of Invent: Health will see our guests debate the efficacy and effectiveness of surgical robotics, seeing whether it’s the future of surgery, or just tech for tech’s sake. We’ll also look to the future to see how big an...
2022-12-1441 min
Invent: HealthHealthcare's coming home: How to fit a hospital into your home
Healthcare’s coming home, it’s coming home… Or is it? Recent years - and increasingly since COVID 19 - have seen healthcare moving into the home, with patients using more digital products to track their health from the comfort of their sofas. But why? What was the initial trigger for this? What are the risks and benefits? Will this see a dystopian world where only the rich see doctors in person or a complete democratisation of convenient healthcare? In this episode of Invent Health we break down healthcare in the home to see the benefits and blockers in the now an...
2022-12-1448 min
Invent: HealthPain: How to feel less pain
What is pain? Where does it start and end? In the mind, nerve endings, or somewhere else? In this final episode of the first season of Invent: Health from TTP, we’ll be exploring the many and varied facets of this most essential of human experiences. Speaking with specialists in the fields of psychology and neuroscience, we’ll find out what is being done to measure pain, to mitigate its severity and what the future of pain relief looks like, to see if people involved in healthcare and drug delivery should be giving pain more attention in their work.
2022-12-1453 min
Invent: HealthInvent: Health from TTP - Season 1 Trailer
Hello and welcome to Invent: Health, a podcast from technology and product development company TTP.Invent: Health is a podcast about the future of health and technology, hosted by TTP Design and Strategy consultant, Matt Millington. Each week, we’ll be joined by the top scientists, designers, business leaders and academics working at the vanguard of this vital industry, to give you a behind-the-scenes look at the world of health tech.See you soon!
2022-12-1402 min
Invent: HealthBonus - Eye health: The Invisible Pandemic
We’re currently taking a short hiatus after our first season, where we covered everything from curing blindness to controlling pain; from making hospitals more sustainable to putting a hospital in your home. Before we come back with season two, our friends over at the Life Sciences team here at TTP are going to be dropping their very own series in the new year. Invent: Life Sciences will be a series looking at all things biology - the efficacy of animal testing, the benefits of synthetic biology, even asking what the infamous team behind The...
2022-12-1444 minInvent: Life SciencesLife Science Investment: How to invest in change
The pandemic drastically altered the landscape for investment flowing into the Life Sciences. Not only was there more money going in, but the market needs changed too, with an unprecedented focus on scaling sectors like testing and vaccines. But what did this mean for sectors which were not on the Covid front line? What happened to the trends that were in train before the pandemic hit? And what have we learnt from this experience that we can deploy in the face of the next global challenge? In this episode of Invent: Life Sciences, we look at the past, present...
2022-07-1944 minInvent: Life SciencesDiagnostics: How to do self-testing better
In the past decade, two events have sent shockwaves through the diagnostics industry: Theranos and Covid. The first, is a parable against faking it in an industry which rightly prizes accuracy and safety. The second was an almost insatiable demand for diagnostic testing kits, where the speed of information took second place to accuracy. Was Elizabeth Holmes onto something when she founded Theranos? What if her devices had been able to live up to the hype? And what reputation does self-testing now have in the diagnostics industry? In this episode of Invent Life Sciences, we take a look at...
2022-07-1248 minInvent: Life SciencesCell Therapy Manufacture: How to scale the manufacture of living drugs
Following our first episode of two focusing on cell and gene therapies, outlining the promise and practicalities of delivering curative therapies for chronic diseases, we now focus on cell therapies - so called ‘living drugs’ that are both as powerful as they are complex. Despite the impressive trials and life-changing impacts at the individual level, it’s still not possible to manufacture cell therapies at scales that could benefit a wider range of patients. So what are the differences between cell therapies and conventional medicines that make them so difficult to manufacture? Can we redeploy hardware and learnings from other...
2022-07-0546 minInvent: Life SciencesCell and Gene: How to make advanced therapies accessible
With therapies like cell and gene - amongst some of the most significant innovations in modern medicine - the idea of delivering cures for conditions from cancer to diabetes is now within the realm of scientific possibility. But will it be possible to provide the benefits of advanced therapies to all? Should we expect our healthcare systems to foot the bill? And can we re-imagine the development ecosystem to truly realise the potential of cell and gene therapies? In this first of two episodes about curing diseases and cell & gene therapies, we outline why we would want to treat...
2022-06-2847 minInvent: Life SciencesPreclinical drug development: How to simulate the human body
From cosmetics to medicines, animal testing is still widely mandated by regulators. Up to now, there have been few other ways to gather information about the potential human response to drug candidates. But are animal models still the most effective way to test drugs before we use them in humans? Or are these in vivo models outdated, ready to be replaced by innovative new in vitro models of drug development? In this episode of TTP Invent: Life Sciences, we take a look at some of the fascinating alternatives to animal testing in drug development, before assessing what new realms...
2022-06-2145 minInvent: Life SciencesAI: How to think differently
The hunt to discover new pharmaceuticals in areas of high unmet need can be complex, time-consuming, and costly. For every life saving therapy that hits the market, thousands and even millions of candidate drugs are rejected. A new technology could be changing the way we home in on the most effective therapy: AI. The use of AI in drug discovery - whether through mining research or in highlighting new experimental insight - is one of the most exciting new sectors in the field. But how does it really work? What are the conditions needed to implement it? Is it...
2022-06-1447 minInvent: Life SciencesSynthetic Biology: How to change your genes
What is the potential of synthetic biology? A chance to create life-changing therapies by speaking cells’ very own language? Or could rogue researchers use it to turn our own biology against us?Since synthetic biology emerged as a field, the aspirations for its benefits have been as speculative as the concerns about its misuse, making one of the most fascinating and divisive fields in life sciences. But what are its real applications today? And where is it going next? In this episode of Invent: Life Sciences we break down the history of this field, focusing in how br...
2022-06-0744 minInvent: Life SciencesGenomics: How to use a $100 genome
When the first human genome was sequenced, the whole project was estimated to have cost some 3 billion dollars and took over 13 years. Now, with massively parallel Next Generation Sequencing it is possible to sequence the human genome in less than 24 hours at a cost of under $1,000. With a rapid decline in sequencing costs, both the number of applications and the amount of data produced have boomed, driving a revolution in medicine. However, with the advent of new enabling technologies, what is next? What are the new and exciting technologies in the sequencing space which will be truly disruptive in...
2022-05-3146 minInvent: Life SciencesInvent: Life Sciences from TTP - Trailer
Following our thrilling first series of Invent all about health technology, the team at TTP are back with a new series all about the Life Sciences, to explore the impact of biology and technology on the life sciences sector.Life sciences are often referred to as the Fourth Industrial Revolution, deploying biology and technology in real-world applications to transform medicine, diagnostics, and ultimately our ability to engineer the building blocks of life itself. From delivering cures using cell therapies to harnessing the genetic code, from learning from the Theranos scandal to understanding disruption in drug discovery, Invent...
2022-05-2402 min
Matrickz Daily TechDailytech 554 - The Biggest Challenge and Opportunities of Autonomous Vehicles (03-01-2021)The time is now for autonomous vehicles. With it comes opportunities and challenges.
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, explained that one of the biggest challenges coming this way is winning public trust. And, on the flip side, one of the biggest opportunities is sharing high utilization vehicles rather than individual car ownership.
Hear more of our fascinating conversation here.
#autonomousvehicle #autonomousvehicles #automotiveindustry #autonomousdriving #automotivesecurity #automotivecybersecurity #automotive #autonomousindustry
2021-06-1402 min
Matrickz Daily TechDailytech 551 - The Diversified Application of Lidar (31-12-2020)Can Lidar companies diversify?
Tom Jellicoe, Consultant for Sensors & Devices at TTP plc, says that it can be useful for a lot of autonomous systems such as the use in mining vehicles, drones, and money vehicles.
Hear his detailed response and our full conversation here.
#sensors #lidar #automotivesensor #autonomousvehicles #autonomousdriving #sensortechnology #sensor #autonomousvehicle #lidarsensor
2021-06-1103 min
Matrickz Daily TechDailytech 548 - The Acquisition of Sensor Companies (28-12-2020)Is there a reason why sensor companies become software companies?
Tom Jellicoe, Consultant for Sensors & Devices at TTP plc, gave a great answer including his analogy to headlight companies who had to adapt as LED lights came out and evolved.
Listen to our full conversation here.
#sensors #lidar #automotivesafety #autonomousvehicles #autonomousdriving #sensortechnology #sensor #autonomousvehicle #lidarsensor
2021-06-0804 min
Matrickz Daily TechDailytech 545 - How Sensors Deal With Unknown Situations (25-12-2020)Can sensors deal with unknown situations in the environment?
This is a big problem in the autonomous vehicle industry. If the situation is unknown, can it be known? In fact, humans might be more capable of handling these types of situations than a sensor.
How can we improve sensors and deal with this challenge?
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, says…
1. We need to record better data.
2. Understand the limitations of the data recording.
Listen to his full re...
2021-06-0505 min
Matrickz Daily TechDailytech 542 - The Main Challenge in Autonomous Vehicle System Sensors (22-12-2020)Is AV a solution to all situations or is that a realistic thought process?
-> John Krafcik, CEO of Waymo, thinks that it’s not realistic to think AV will be a solution to all situations.
-> Enthusiastic like Elon Musk believe AV can be a solution to most, if not all, situations.
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, gave his thoughts on the topic, specifically when it comes to the safety feature of sensors.
Listen to his fascinating response here.
...
2021-06-0205 min
Matrickz Daily TechDailytech 539 - The Diversity Aspects of Hiring People (19-12-2020)What is the main difference between TTP plc and other companies in the space?
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, says it comes down to the vast amount of diversity in experience TTP employees have.
“We’ve got just under 300 technical staff at TTP, spanning pretty much every discipline of engineering and science,” Tom said.
Listen to his detailed response here.
#sensors #automotivesafety #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #methodologies #methodology
2021-05-3003 min
Matrickz Daily TechDailytech 537 - Methodological Advice for Solving Technological Challenges (17-12-2020)How do you solve challenges?
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices TTP plc, recommends a methodical approach including:
➡️ Getting into the details and understanding the challenge.
➡️ Looking at how existing technologies might address it.
➡️ Talking with a full team who has various skill sets.
➡️ Modeling and assessing concepts.
Listen to his full and detailed explanation here.
#sensors #automotivesafety #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #methodologies #methodology
2021-05-2803 min
Matrickz Daily TechDailytech 535 - The Safety Aspect of Sensor Cleaning (15-12-2020)What’s the point of sensor cleaning?
Unlike humans that just peer around dirt that gets tracked on their windshield, sensors rely on being able to fully use all portions of the sensor.
In my fascinating conversation with Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, he said that sensor cleaning is essential to ensuring the critical safety system is fully operational.
Hear more of his explanation here.
#sensors #lidar #automotivesafety #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #lidarsensor
2021-05-2603 min
Matrickz Daily TechDailytech 533 - How to Solve The Sensor Cleaning Challenges (13-12-2020)What’s one of the biggest challenges of sensor systems?
Keeping sensors clean!
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, discusses how TTP finds unique solutions for this challenge and integrating them into their client’s products.
Hear more of his explanation by listening to our fascinating conversation.
#sensors #lidar #ultrasoniccleaning #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #lidarsensor #radarsensor
2021-05-2406 min
Matrickz Daily TechDailytech 531 - The Challenges of Sensor Systems (11-12-2020)Are there challenges when it comes to sensor systems?
Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, says that one challenge, which seems simple, is one of the biggest challenges - keeping the sensors clean and available 100% of the time to the vehicle.
There are a couple of challenges including knowing when the sensor needs to be clean and answering the question - who’s responsibility is it to keep clean?
#sensors #lidar #ultrasoniccleaning #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #lidarsensor #radarsensor
2021-05-2207 min
Matrickz Daily TechDailytech 529 - The Reasons Why There Are So Many Aspects of LiDAR Sensor (09-12-2020)How many aspects of a sensor system are there? When it comes to LiDAR (Light Detection and Ranging), it’s all unique.
There are so many parts of a LiDAR sensor and developing each one is difficult, said Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc.
#sensors #lidar #ultrasoniccleaning #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle #lidarsensor #radarsensor
2021-05-2006 min
Matrickz Daily TechDailytech 526 - How Sensor Systems Will Help Autonomous Vehicles (06-12-2020)Do autonomous vehicle system senses help the autonomous vehicle or Advanced driver-assistance systems space?
According to Tom Jellicoe, a consultant for Sensors & Devices at TTP plc, yes it does.
Hear more about his response and reasoning here.
#sensors #lidar #ultrasoniccleaning #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle
2021-05-1705 min
Matrickz Daily TechDailytech 523 - Why Is the Autonomous Industry Slower than the Traditional IT Industry? (03-12-2020)Have you ever wondered why the autonomous industry is slower than the traditional IT industry?
For one, Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, says that the automotive industry is rigid, and taking on such technical risks would not be a great business decision.
Additionally, the quality of the car matters, and bringing new technology up to standard is a real challenge.
Listen to more of his explanation about this here.
#sensors #lidar #ultrasoniccleaning #autonomousvehicles #autonomousdriving #sensorcleaning #sensortechnology #sensor #autonomousvehicle
2021-05-1403 min
Matrickz Daily TechDailytech 520 - The Background of Tom Jellicoe (30-11-2020)Which do you prefer - solving scientific problems or challenges that affect the world right now?
For Tom Jellicoe, Cambridge Ph.D. in physics and consultant for Sensors & Devices at TTP plc, his journey started in one and has evolved into the other.
In my fascinating discussion with Tom, he said, “I really enjoyed the elements of research and solving scientific problems, but my passion really is working on challenges that are going to affect the real world in a way that I can measure myself.”
Listen to more of his journey here.
2021-05-1105 min
Autonomous Vehicle Safety & SecurityAutonomous Vehicle System Sensors (2020)The main challenge in the autonomous vehicle industry is that we try to replace the human driver with the machine or software. Many technologies have been created to help us make this happen, one of them is the system sensor.Sensors such as LiDar, Radar, cameras have a very important role, which is to function as the eye of an autonomous vehicle. Much like human drivers, autonomous vehicles rely on optical sensors to understand their environment and identify hazards.One such challenge is when a sensor’s view of th...
2020-11-1759 min